A new paper describes a novel class of non-nucleoside reverse transcriptase inhibitors for HIV associated neurocognitive disorders (HAND) RALEIGH, NC, USA, May 2, 2023 /EINPresswire.com/ -- Collaborations Pharmaceuticals, Inc. (CPI) with …
Continue reading...
Continue reading...